Transvitreal endocyclophotocoagulation

Case-Matched Comparison of Vitrectomy, Peripheral Retinal Endolaser, and Endocyclophotocoagulation Versus Standard Care in Neovascular Glaucoma

“…For instance, in a retrospective case review of 73 eyes, Haller transvitreal cyclophotocoagulation. 18 Visual acuity improved or remained stable in 53 of 73 eyes (73%) in the study by Haller et al and in 25 of 27 eyes (92.6%) in our case series of ECP. At the last follow-up visit, 36 of 55 eyes (65.5%) no longer required glaucoma medications after transvitreal cyclophotocoagulation in the study by Haller et al In our study, 20 of 27 eyes (74.0%) in the ECP group no longer required glaucoma medications to maintain IOP within normal limits.…”

Effectiveness of Transscleral Cyclophotocoagulation as Adjuvant Therapy for Refractory Glaucoma in Keratoprosthesis Patients

“…The IOP of 20% of patients was restored to normal by a single treatment, whereas other patients required medication to reduce intraocular hypertension, and some patients needed repeat DLTSC, possibly due to anterior or posterior displacement of the borders of the ciliary body that occurred before or after keratoprosthesis surgery (11, 12). The exact anatomic region of the cornea is difficult to identify during aqueous shunt placement due to severe injury and the high rate of postoperative fibrosis when lip mucosa or ear cartilage are used as the tube implants (13). However, glaucoma shunt surgery has demonstrated significant therapeutic effect in patients with pharmaceutically uncontrolled glaucoma and keratoprostheses (5, 14, 15).…”

Corneal Transplantation and Glaucoma

“…136,137 Haller reports successful control of IOP with transvitreal ECP in 93% of eyes at one year and 86% of eyes at last follow-up with 71% maintaining or improving visual acuity. Huang et al prospectively compared ECP with transscleral CPC after PK.…”